In this powerful conversation, Sergey Badalyan, Assistant Managing Editor at OncoDaily Medical Journal, speaks with Dr. Jennifer Chun Kim, Executive Director of the Stephenson Global Pancreatic Cancer Research Institute. This discussion explores whether cancer research is entering a structural shift in how innovation is funded.
Dr. Jennifer Chun Kim talks about:
- Funding challenges in pancreatic cancer and its impact on survival rates
- Why young investigators are leaving academic science
- Why the $128M boost to the National Cancer Institute still feels insufficient for researchers on the ground
- Groundbreaking work on KRAS targeted therapy
- Why investing early in young scientists is critical to doubling survival rates in the next decade